EP Patent

EP2847165A2 — Indole, indoline derivatives, compositions comprising them and uses thereof

Assigned to Yissum Research Development Co of Hebrew University of Jerusalem · Expires 2015-03-18 · 11y expired

What this patent protects

The invention provides indole and indoline derivatives and slats thereof, compositions comprising them and uses thereof for the treatment of diseases and disorders.

USPTO Abstract

The invention provides indole and indoline derivatives and slats thereof, compositions comprising them and uses thereof for the treatment of diseases and disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP2847165A2
Jurisdiction
EP
Classification
—
Expires
2015-03-18
Drug substance claim
No
Drug product claim
No
Assignee
Yissum Research Development Co of Hebrew University of Jerusalem
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.